Abstract:Microvascular destabilization is the primary cause of the inner blood-retinal barrier (iBRB) breakdown and increased vascular leakage in diabetic retinopathy (DR). Microvascular destabilization results from the combinational effects of increased levels of growth factors and cytokines, involvement of inflammation, and the changed cell-to-cell interactions, especially the loss of endothelial cells and pericytes, due to hyperglycemia and hypoxia. As the manifestation of microvascular destabilization, the fluid transports via paracellular and transcellular routes increase due to the disruption of endothelial intercellular junctional complexes and/or the altered caveolar transcellular transport across the retinal vascular endothelium. With diabetes progression, the functional and the structural changes of the iBRB components, including the cellular and noncellular components, further facilitate and aggravate microvascular destabilization, resulting in macular edema, the neuroretinal damage and the dysfunction of retinal inner neurovascular unit (iNVU). Although there have been considerable recent advances towards a better understanding of the complex cellular and molecular network underlying the microvascular destabilization, some still remain to be fully elucidated. Recent data indicate that targeting the intricate signaling pathways may allow to against the microvascular destabilization. Therefore, efforts have been made to better clarify the cellular and molecular mechanisms that are involved in the microvascular destabilization in DR. In this review, we discuss: (1) the brief introduction of DR and microvascular destabilization; (2) the cellular and molecular components of iBRB and iNVU, and the breakdown of iBRB; (3) the matrix and cell-to-cell contacts to maintain microvascular stabilization, including the endothelial glycocalyx, basement membrane, and various cell-cell interactions; (4) the molecular mechanisms mediated cell-cell contacts and vascular cell death; (5) the altered cytokines and signaling pathways as well as the intricate network of the cytokines involved in microvascular destabilization. This comprehensive review aimed to provide the insights for microvascular destabilization by targeting the key molecules or specific iBRB cells, thus restoring the function and structure of iBRB and iNVU, to treat DR.

Research progress in regulatory factors of ischemia-reperfusion injury induced by diabetic retinopathy

Inflammatory Machenism in the Pathogenesis of Diabetic Retinopathy

Role of Pericytes in Mechanisms of Diabetic Retinopathy

The current status and progress of the pathological changes and related molecular mechanisms of neuroretinal injury in diabetic retinopathy

The pathophysiological mechanisms underlying diabetic retinopathy

Research progresses of inflammatory cytokines associated with diabetic retinopathy

Advances of Regulation of Endoplasmic Reticulum Stress and HIF-1 to VEGF in Diabetic Retinopathy

An overview of the pathogenesis of diabetic retinopathy

Oxidative Stress-Related Mechanisms and Antioxidant Therapy in Diabetic Retinopathy

Effects of CXC chemokines and CXC chemokine's receptors on diabetic retinopathy

Research Progress of Retinal Ischemia Reperfusion Injury and Cytokines

Molecules related to diabetic retinopathy in the vitreous and involved pathways

Recent advances in the treatment and delivery system of diabetic retinopathy

Microvascular destabilization and intricated network of the cytokines in diabetic retinopathy: from the perspective of cellular and molecular components

Research progress on the mechanism of ferroptosis and its role in diabetic retinopathy

Hypoxia-inducible factor-1α: A promising therapeutic target for vasculopathy in diabetic retinopathy

Diabetes Promotes Retinal Vascular Endothelial Cell Injury by Inducing CCN1 Expression

Protective factors in diabetic retinopathy: focus on blood-retinal barrier.

Study progress of HIF-1 regulation mechanisms in diabetic retinopathy and neuropathy

Mechanism of inflammation in diabetic retinopathy

Neurovascular regulation in diabetic retinopathy and emerging therapies